Status: Not yet recruiting
CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)
This clinical investigation is intended to confirm the application of a new intended purpose and a new indication for an already certified medical device. Therefore, it is a pivotal clinical investigation with a confirmatory type of design.
Participants needed: 240
Trial details
Age: 45-65Biological sex: AllType: InterventionalSponsor: Certmedica International GmbHUpdated: Apr 4, 2025Locations: 3
Eligibility criteria
Outpatients of both genders, with CIMT > 1.00 mm suffering from hypertension and... [+11]
Age < 45 or > 65 years. [+29]